[Public Notice+] Classys "Achieved Record High Performance in Q4 Last Year"

[Asia Economy Reporter Hyunseok Yoo] Classys announced on the 6th that it recorded its highest-ever performance in the fourth quarter of last year.

Classys recorded sales of 22.3 billion KRW and operating profit of 12.9 billion KRW in the fourth quarter of last year. This represents an increase of 53% and 98%, respectively, compared to the same period of the previous year. Additionally, last year's sales reached 81.1 billion KRW, a 71% increase year-on-year, and operating profit rose by 138% to approximately 41.7 billion KRW. The operating profit margin was 51.3%, meaning more than half of the sales amount was attributed to profit.

Classys develops, manufactures, and markets beauty medical devices independently. Through its corporate research institute, it internalizes core technologies and successfully leads marketing targeting both doctors who use the devices and general consumers who receive services through beauty medical devices. In particular, the company explained that its flagship product, Shurink, has led the popularization of the domestic beauty medical market, and as its recognition expands in overseas markets, profit growth driven by external growth is accelerating.

A company official stated, "As Shurink has established itself as a brand, awareness and usage rates of various cartridges such as Eye Shurink, V Shurink, and S Shurink are also increasing," adding, "Recently, programs combining our products, such as Shurink with Alpha and Shurink with Ulfit, have also received favorable reviews." The official continued, "For sustainable growth, we plan to actively promote the global brand expansion of Shurink as well as actively sell Alpha, Ulfit, TonerB, AquaPure, and other products. We will also strengthen our product lineup by preparing for the launch of new products such as Volnum."

This content was produced with the assistance of AI translation services.